Poststroke depression and soluble suppression of tumorigenicity 2

descriptionPublicationkeyboard_double_arrow_right Article 13 Apr 2021 English Publisher:WileyJournal:European Journal of Neurology, volume 28 (issn: 1351-5101, eissn: 1468-1331,

Copyright policy )

Authors: Meidi Peng; Yachi Gong; Hongtao Huang;

doi: 10.1111/ene.14856

pmid: 33817922

Poststroke depression and soluble suppression of tumorigenicity 2

- Summary
- Subjects
- Metrics

Abstract

Recently, we have read the original article written by Yaling Lu et al1 , which was published in European Journal of Neurology [1]. The authors enrolled 635 acute ischemic stroke patients with soluble suppression of tumorigenicity 2 (sST2) measurements from the China Antihypertensive Trial in Acute Ischemic Stroke, one multicenter randomized clinical trial in China, to explore the relationship between sST2 and post-stroke depression (PSD).

Related Organizations

Nantong University
China (People's Republic of)

Keywords

Stroke, Depressive Disorder, Depression, Humans

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	0
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average